Showing results (71-80 of 245) with videos related to

Sort By:
Pageof 25
European Urology|June 17, 2022
Obesity in Relation to Renal Cell Carcinoma Incidence and Survival in Three Prospective StudiesRebecca E Graff, Kathryn M Wilson, Alejandro Sanchez, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2018
A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer ModelJunhui Hu, Shiruyeh Schokrpur, Maani Archang, et al.
The Journal of Urology|May 11, 2017
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic ImplicationsStephanie A M Wankowicz, Lillian Werner, Anna Orsola, et al.
Clinical Genitourinary Cancer|May 23, 2016
Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor CellularityQing Yuan, Payal Kapur, Yue Zhang, et al.
BJU International|March 17, 2010
Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapyToni K Choueiri, Meredith M Regan, Jonathan E Rosenberg, et al.
Cancer Cell|October 20, 2012
The requirement for cyclin D function in tumor maintenanceYoon Jong Choi, Xiaoyu Li, Per Hydbring, et al.
Radiology|February 18, 2010
Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathwaysStephanie A Solazzo, Muneeb Ahmed, Rachel Schor-Bardach, et al.
Cancer Research|April 19, 2005
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasionArnold H Zea, Paulo C Rodriguez, Michael B Atkins, et al.
Developmental Cell|August 5, 2014
D-cyclins repress apoptosis in hematopoietic cells by controlling death receptor Fas and its ligand FasLYoon Jong Choi, Borja Saez, Lars Anders, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2022
Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical dataLaurence Albiges, Daniel Y C Heng, Jae Lyun Lee, et al.
Pageof 25